tiprankstipranks
Trending News
More News >

Livzon Pharmaceutical Group Announces Board Composition and Committee Memberships

Story Highlights
  • Livzon Pharmaceutical Group focuses on pharmaceutical products and healthcare solutions.
  • The company announced its board and committee memberships, impacting governance and strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Livzon Pharmaceutical Group Announces Board Composition and Committee Memberships

Confident Investing Starts Here:

Livzon Pharmaceutical Group ( (HK:1513) ) has issued an announcement.

Livzon Pharmaceutical Group Inc. has announced the composition of its board of directors and the membership of its board committees. This announcement provides clarity on the leadership structure of the company, which could influence its strategic direction and governance practices, potentially impacting stakeholders and the company’s market positioning.

The most recent analyst rating on (HK:1513) stock is a Sell with a HK$24.00 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.

More about Livzon Pharmaceutical Group

Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its comprehensive range of healthcare solutions, catering to various market needs.

Average Trading Volume: 1,090,004

Technical Sentiment Signal: Buy

Current Market Cap: HK$31.19B

For an in-depth examination of 1513 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App